ARCHIVES

JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials

This article is from The Cancer Letter archive.

Vol. 36 No. 42 | November 19, 2010

Download PDF Visit The Full Archive

Related Articles

New NCI division For Center, Training, Organ Systems, Construction Seen As Likely Prospect

April 17, 1987

Concepts for New, Recompeted DCCP Contracts Approved

June 12, 1981

Philadelphia Group Begins BMT Trial for Breast Cancer

April 5, 1991

Pre-Emptive Treatment Helped Curtail Panitumumab Toxicity

January 30, 2009

Also: Court Will Reconsider Ruling on Access To Experimental Drugs.

December 1, 2006

Experts Say Interpretable Results Unlikely In Burzynski’s Antineoplastons Studies

September 25, 1998